Inflection Point Acquisition Corp. VI Announces Pricing of $220 Million Initial Public Offering

Rhea-AI Summary

Inflection Point Acquisition Corp. VI (IPFX) priced a $220.0 million IPO of 22,000,000 units at $10.00 per unit, each unit comprising one Class A share and one-third warrant. Units begin trading as IPFXU on Nasdaq on March 27, 2026.

The offering is expected to close March 30, 2026, with a 45-day underwriter option for an additional 3,300,000 units; warrants have an $11.50 exercise price and separate tickers IPFX and IPFXW when split.

Positive

• $220.0M IPO proceeds from 22,000,000 units
• Listing on Nasdaq under ticker IPFXU beginning March 27, 2026
• Underwriters granted 3,300,000-unit over-allotment option (45 days)

Negative

• Each unit includes 1/3 warrant, creating potential dilution on exercise
• Warrant exercise price at $11.50 may still dilute shareholders if exercised
• Closing is subject to customary conditions, so the offering could fail to close

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Miami Beach, FL , March 27, 2026 (GLOBE NEWSWIRE) -- Inflection Point Acquisition Corp. VI (the “Company”), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, today announced the pricing of its initial public offering of 22,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global Market, or Nasdaq, and trade under the ticker symbol “IPFXU” beginning March 27, 2026. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share (subject to adjustment pursuant to certain anti-dilution rights). Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “IPFX” and “IPFXW,” respectively.

The Company intends to pursue a business combination with a North American or European business in disruptive growth sectors, which complements the expertise of its management team, but may pursue an initial business combination in any industry, sector or geographic region. The Company is led by Chief Executive Officer Kevin Shannon, Chief Financial Officer Adam Saks, Chairman and Director Michael Blitzer, and Directors William Denkin, Christopher Kellen, Steven Tannenbaum, and Carolyn Trabuco.

The offering is expected to close on March 30, 2026, subject to customary closing conditions.

Cantor Fitzgerald & Co. is acting as book-running manager and Academy Securities, Inc. is acting as co-manager for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,300,000 units to cover over-allotments, if any.

A registration statement on Form S-1 (File No. 333-292443), as amended, relating to the securities was declared effective by the Securities and Exchange Commission (“SEC”) on March 26, 2026. The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from: Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, New York 10022; Email: prospectus@cantor.com or by accessing the SEC’s website, www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements," including with respect to the expected closing of the proposed initial public offering and search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and preliminary prospectus for the Company's offering filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

About Inflection Point Acquisition Corp. VI

Inflection Point Acquisition Corp. VI’s acquisition and value creation strategy is to identify, partner with and help grow North American and European businesses in disruptive growth sectors, which complements the expertise of its management team. However, the Company may pursue an initial business combination in any industry, sector or geographic region.

Contact
Kevin Shannon
Inflection Point Acquisition Corp. VI
info@inflectionpointacquisition.com

FAQ

What did Inflection Point Acquisition Corp. VI (IPFX) price its IPO at and when does trading begin?

IPFX priced 22,000,000 units at $10.00 per unit, with units trading as IPFXU beginning March 27, 2026. According to the company, the offering is expected to close on March 30, 2026, subject to customary closing conditions.

How much total capital will IPFX raise from the offering and is there an over-allotment option?

The offering is sized at $220.0 million from the base 22,000,000 units. According to the company, underwriters have a 45-day option to purchase up to an additional 3,300,000 units to cover over-allotments.

What securities does each IPFX unit include and what are the post-split ticker symbols?

Each unit contains one Class A ordinary share and one-third of a redeemable warrant. According to the company, once separated, the Class A shares and warrants are expected to list as IPFX and IPFXW, respectively.

What is the warrant exercise price for IPFX and are there anti-dilution provisions?

Each whole warrant entitles purchase of one Class A share at an exercise price of $11.50. According to the company, the exercise price is subject to adjustment pursuant to certain anti-dilution rights.

Who are the lead managers for IPFX’s IPO and how can investors obtain the prospectus?

Cantor Fitzgerald is the book-running manager and Academy Securities is co-manager for the offering. According to the company, the prospectus can be requested from Cantor Fitzgerald or accessed on the SEC website when available.

What types of targets will IPFX seek for its business combination and are there geographic limits?

IPFX intends to pursue a business combination with a North American or European business in disruptive growth sectors but may consider any industry, sector, or geographic region. According to the company, target selection complements management expertise.